Error 404 - Not Found

Suggestions

YouTube Calendar Photos Documents Sites Groups Reader

Search



Vioxx news and articles 5/6/2010 - New research shows that information on potentially lethal side effects of the Merck Sat on Data Showing Vioxx Risks for Years Before Pulling Drug whistleblowers and government investigations , the FDA continues to ignore its . Leaked documents show Merck knew of Vioxx dangers, yet hid them for years

VIOXX AND THE MERCK TEAM EFFORT the entire document and attribute the source: The Kenan Institute for Ethics at On May 20, 1999, the FDA approved Merck's application to market Vioxx , a approval for a new product – it also needed to make sure the drug was successfully . was known as the VIGOR ( Vioxx Gastrointestinal Outcomes Research ) study,

Vioxx Recall Lawsuit Heart Attack Lawyer Merck wanted to conduct a trial to prove Vioxx was gentler on the stomach But to show the difference most clearly, the Vioxx patients couldn't take any aspirin. . of my co-authors, and I think it's safe to say they share these same conclusions " said in a statement after committee investigators interviewed the researcher .

Vioxx - SourceWatch Jan 9, 2011 Vioxx is a subsection of the main SourceWatch article Merck. It was not until 2004 that strong, publicly available research tied Vioxx (a COX-2 a major role in making people think Vioxx was safer and more effective than it is. . The documents show that Merck exerted pressure not only on individual

Documents Suggest Merck Tried to Censor Vioxx Critics - NPR The documents show that Merck exerted pressure not only on individual Merck wanted Singh on board because he was a senior researcher on a seminal study of arthritis patients For some researchers , the results were a red flag that Vioxx might be dangerous The company confirmed that Vioxx was safe for the heart.

Merck & Company Inc. (MRK) News - Company Information - The The biggest of them has been Vioxx , the pain medication that Merck had touted when internal company documents were revealed that showed that Merck's the seven-year investigation by the United States attorney in Massachusetts and that the Food and Drug Administration has determined are safe and beneficial.

Rofecoxib - Wikipedia, the free encyclopedia This was largely based on the VIGOR ( Vioxx GI Outcomes Research ) study, which . "Internal emails show the New England Journal's expression of concern was . further study was needed for all NSAIDs to fully understand their risk profiles. to investigate Vioxx study results and communications conducted by Merck.

Vioxx Lawsuit Vioxx Trial Merck Wins First California VIOXX (R) Case … second time in the past month that the painkiller Vioxx , a lawmaker alleged Wednesday in seeking an investigation … . Withhold or otherwise concealing critical research or clinical data from the dollars in DTC advertising to persuade the public that Vioxx offered safe and

Publication Bias in Meta-Analysis Publication bias is the term for what occurs whenever the research that quences, as when an ineffective or dangerous treatment is falsely viewed as safe and Merck's recall of Vioxx , a popular arthritis drug (Merck maintained that it the first systematic investigations of publication bias focused on this aspect of the

Special Report-Giles-4 Vioxx —the emails, memos, reports—have been made public. The documents show that this self-regulation . researchers that supported his findings. Merck sell Vioxx in large quantities, Merck needed to con- safer than the painkillers that they were already pre- .. US department of justice launched an investigation .

Advertising Programs       Business Solutions       New Privacy & Terms       About Google